XML 48 R34.htm IDEA: XBRL DOCUMENT
v3.26.1

Intangible Assets (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract] |
Schedule of Research and Development | Intangible assets, net consisted of the following: Schedule of Intangible Assets, Net
|  | December 31, 2025
|  | Weighted-Average |  | Gross |  |  |  |  |  | Net |
|  | Useful Life |  | Carrying |  |  | Accumulated |  |  | Carrying |
|  | (in Years) |  | Amount |  |  | Amortization |  |  | Amount |
In-process research and development |  | Indefinite |  | $ | 7,219,000 |  |  | $ | - |  |  | $ | 7,219,000 |
Non-competition agreements |  |  |  |  | 1,094,000 |  |  |  | (1,094,000 | ) |  |  | - |
Total intangible assets |  |  |  | $ | 8,313,000 |  |  | $ | (1,094,000 | ) |  | $ | 7,219,000 |
|  | December 31, 2024
|  | Weighted-Average |  | Gross |  |  |  |  |  | Net |
|  | Useful Life |  | Carrying |  |  | Accumulated |  |  | Carrying |
|  | (in Years) |  | Amount |  |  | Amortization |  |  | Amount |
In-process research and development |  | Indefinite |  | $ | 26,101,000 |  |  | $ | - |  |  | $ | 26,101,000 |
Non-competition agreements |  |  |  |  | 1,094,000 |  |  |  | (1,094,000 | ) |  |  | - |
Total intangible assets |  |  |  | $ | 27,195,000 |  |  | $ | (1,094,000 | ) |  | $ | 26,101,000 |
The Company completed its impairment test for the in-process research and development during the fourth quarter of 2025, resulting in a partial impairment of the intangible asset which is reflected in impairment charges on the consolidated statements of operations and comprehensive loss for the year ended December 31, 2025. The Company did not record any impairment during the year ended December 31, 2024. Changes in the Company’s in-process research and development for the year ended December 31, 2025 were as follows: Schedule of Research and Development
Balance as of December 31, 2024 |  | $ | 26,101,000 |
Impairment of in-process research and development |  |  | (18,882,000 | )
Balance as of December 31, 2025 |  | $ | 7,219,000 |
Schedule of Research and Development | Changes in the Company’s in-process research and development for the year ended December 31, 2025 were as follows: Schedule of Research and Development
Balance as of December 31, 2024 |  | $ | 26,101,000 |
Impairment of in-process research and development |  |  | (18,882,000 | )
Balance as of December 31, 2025 |  | $ | 7,219,000 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements. Include also the amount of costs incurred under a research and development arrangement accounted for as a contract to perform research and development for others. Aggregation of similar arrangements by type may be appropriate. Include also the amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others. Aggregation of similar arrangements by type may be appropriate. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 730 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 730 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1 + Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name Accounting Standards Codification -Section 55 -Paragraph 40 -SubTopic 30 -Topic 350 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration